Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × fludarabine phosphate × Tumor-Agnostic × Clear all

Phase

Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 94 Lymphoid 79 Myeloid 39 Plasma cell 25 Dermatologic 21 Sarcoma 13 Classical hematology 12 Gastrointestinal 11 Head & Neck 9 CNS 9 Gynecologic 8 Thoracic 6 Genitourinary 5 Breast 5 Other solid neoplasm 4 Tumor-Agnostic 1 NET 1 Endocrine 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 40 Paclitaxel 38 Gemcitabine 31 Carboplatin 31 Docetaxel 28 Bevacizumab 22 Cisplatin 20 Nivolumab 18 Irinotecan 17 Magnetic Resonance Spectroscopy 16 Fluorouracil 16 Erlotinib Hydrochloride 16 Sorafenib 15 Pemetrexed 15 Afatinib 14 regorafenib 13 Specimen Handling 13 Capecitabine 13 Leucovorin 12 Cetuximab 12 Biopsy 12 olaparib 11 trametinib 10 Oxaliplatin 10 epothilone B 9 Injections 9 lenvatinib 8 eribulin 8 Topotecan 8 Everolimus 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02775292 2025-07-30

NYM

Jonsson Comprehensive Cancer Center

Phase 1 Completed

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡